The Global PAD Association has presented the 2025 Walking As Therapy Breakthrough Research of the Year award to The STRIDE Trial Research Team led by Dr. Marc P. Bonaca

AURORA, CO / ACCESS Newswire / September 5, 2025 / The Global PAD Association has presented the 2025 Walking As Therapy Breakthrough Research of the Year award to The STRIDE Trial Research Team led by Dr. Marc P. Bonaca, Executive Director at CPC Clinical Research, for pioneering research demonstrating significant improvements in walking capacity, symptoms, and quality of life for peripheral artery disease patients through innovative therapeutic intervention. The STRIDE trial represents a landmark advancement that transforms our understanding of walking therapy and opens new frontiers in PAD treatment. The STRIDE trial results were presented at the American College of Cardiology scientific sessions in March 2025 and simultaneously published in the Lancet.

Dr. Marc P. Bonaca can be reached by media at info@cpcmed.org or 303-860-9900.

CPC press contact: info@cpcmed.org

CPC Clinical Research & CPC Community Health
2115 N. Scranton St., Suite 2040
Aurora, CO 80045-7120

About CPC Clinical Research

CPC Clinical Research is an academic research organization affiliated with the University of Colorado that is recognized for its expertise in innovative, pragmatic clinical trial design & management for both national and international clinical research. CPC has over 30 years of experience in managing all stages and types of clinical trials.

For more information, please visit https://cpcclinicalresearch.org/

SOURCE: CPC

View the original press release on ACCESS Newswire

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

13 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

18 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

19 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

19 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

19 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

24 hours ago